Cancer BiologybioRxivPreprint
Targeting PI3Kβ-dependent cancer with a novel small molecule inhibitor, GT220
Qi Wang, Huimin Cheng, Xiangyang Yu…·Jean J. Zhao
This paper develops GT220, a selective PI3Kβ inhibitor, showing efficacy in PTEN-deficient cancers while sparing normal cells.
DOI 10.64898/2026.01.16.699992